TrademarksHub.

UAE trademark · No. 1686213 · IR 1686213

UAE logo trademark No. 1686213

status
Madrid designation published
class
5 · Pharmaceuticals & medical preparations
Logo mark No. 1686213 — UAE trademark, Class 5, No. 1686213
Madrid designation published

Check your own name against this and every other UAE mark before you file.

Trademark details

MarkFigurative (logo) mark
Application number1686213
International registrationIR 1686213 (Madrid)
ClassesClass 5 Pharmaceuticals & medical preparations, Class 10 Medical & veterinary apparatus, Class 42 Scientific, technology & software services, Class 44 Medical, beauty & agricultural services
StatusMadrid designation published
Published16 February 2024 · Bulletin No. 288

About this trademark

This logo mark is a trademark on the UAE register under application number 1686213 (international registration 1686213 under the Madrid System).

It covers Class 5 (Pharmaceuticals & medical preparations), Class 10 (Medical & veterinary apparatus), Class 42 (Scientific, technology & software services), Class 44 (Medical, beauty & agricultural services).

It was accepted and published in the UAE Trademark Bulletin No. 288 on 16 February 2024.

Goods and services

As filed with the Ministry of Economy and Tourism. Protection covers only what is listed.

5 - Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of diabetic macular edema; pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders.~10 - Medical and surgical instruments and apparatus for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders; drug delivery devices for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders.~42 - Drug discovery services relating to ophthalmic diseases and disorders; drug discovery services relating to diabetic macular edema; drug discovery services relating to angioedema; drug discovery services relating to hereditary angioedema; drug discovery services relating to diseases and disorders mediated by the contact activation system; drug discovery services relating to plasma kallikrein or factor XIIa mediated diseases or disorders.~44 - Medical and healthcare services relating to ophthalmic diseases and disorders; medical and health care services relating to diabetic macular edema; medical and healthcare services relating to angioedema; medical and healthcare services relating to hereditary angioedema; medical and healthcare services relating to diseases and disorders mediated by the contact activation system; medical and healthcare services relating to plasma kallikrein or factor XIIa mediated diseases or disorders.

Gazette history

  • Madrid mark published in the UAE · No. 28816 February 2024

Explore

Class 5 explainedClass 5 marks open for opposition Status check

Source: UAE Trademark Bulletin (Ministry of Economy and Tourism) as read by TrademarksHub; renewal date worked out from the filing date. Trademark data only — owner details are not published on this site. Check the official register before acting. Not legal advice.